<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-03-27" modified="2020-10-07" version="178">
<accession>Q9Y2R2</accession>
<accession>A0N0K6</accession>
<accession>B1ALC8</accession>
<accession>D4NZ71</accession>
<accession>E9PLD8</accession>
<accession>E9PPI1</accession>
<accession>O95063</accession>
<accession>O95064</accession>
<accession>Q6IPX8</accession>
<accession>Q8WVM1</accession>
<name>PTN22_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein phosphatase non-receptor type 22</fullName>
<ecNumber evidence="27">3.1.3.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP</fullName>
</alternativeName>
<alternativeName>
<fullName>Lymphoid phosphatase</fullName>
<shortName>LyP</shortName>
</alternativeName>
<alternativeName>
<fullName>PEST-domain phosphatase</fullName>
<shortName>PEP</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTPN22</name>
<name type="synonym">PTPN8</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Blood" volume="93" first="2013" last="2024">
<title>Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.</title>
<authorList>
<person name="Cohen S."/>
<person name="Dadi H."/>
<person name="Shaoul E."/>
<person name="Sharfe N."/>
<person name="Roifman C.M."/>
</authorList>
<dbReference type="PubMed" id="10068674"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2010" name="BMC Mol. Biol." volume="11" first="78" last="78">
<title>Identification of a variant form of tyrosine phosphatase LYP.</title>
<authorList>
<person name="Wang S."/>
<person name="Dong H."/>
<person name="Han J."/>
<person name="Ho W.T."/>
<person name="Fu X."/>
<person name="Zhao Z.J."/>
</authorList>
<dbReference type="PubMed" id="21044313"/>
<dbReference type="DOI" id="10.1186/1471-2199-11-78"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="3">
<citation type="submission" date="1998-07" db="EMBL/GenBank/DDBJ databases">
<title>Human protein tyrosine phosphatase (70zpep) homolog.</title>
<authorList>
<person name="Liu T."/>
<person name="Zhang J."/>
<person name="Fu G."/>
<person name="Zhang Q."/>
<person name="Ye M."/>
<person name="Zhou J."/>
<person name="Wu J."/>
<person name="Shen Y."/>
<person name="Yu M."/>
<person name="Chen S."/>
<person name="Mao M."/>
<person name="Chen Z."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Livingston R.J."/>
<person name="Shaffer T."/>
<person name="McFarland I."/>
<person name="Nguyen C.P."/>
<person name="Stanaway I.B."/>
<person name="Rajkumar N."/>
<person name="Johnson E.J."/>
<person name="da Ponte S.H."/>
<person name="Willa H."/>
<person name="Ahearn M.O."/>
<person name="Bertucci C."/>
<person name="Acklestad J."/>
<person name="Carroll A."/>
<person name="Swanson J."/>
<person name="Gildersleeve H.I."/>
<person name="Nickerson D.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 5)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="11002" last="11010">
<title>Identification of substrates of human protein-tyrosine phosphatase PTPN22.</title>
<authorList>
<person name="Wu J."/>
<person name="Katrekar A."/>
<person name="Honigberg L.A."/>
<person name="Smith A.M."/>
<person name="Conn M.T."/>
<person name="Tang J."/>
<person name="Jeffery D."/>
<person name="Mortara K."/>
<person name="Sampang J."/>
<person name="Williams S.R."/>
<person name="Buggy J."/>
<person name="Clark J.M."/>
</authorList>
<dbReference type="PubMed" id="16461343"/>
<dbReference type="DOI" id="10.1074/jbc.m600498200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Autoimmunity" volume="40" first="453" last="461">
<title>Protein tyrosine phosphatase PTPN22 in human autoimmunity.</title>
<authorList>
<person name="Vang T."/>
<person name="Miletic A.V."/>
<person name="Bottini N."/>
<person name="Mustelin T."/>
</authorList>
<dbReference type="PubMed" id="17729039"/>
<dbReference type="DOI" id="10.1080/08916930701464897"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E33067" last="E33067">
<title>PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis.</title>
<authorList>
<person name="Chang H.H."/>
<person name="Tai T.S."/>
<person name="Lu B."/>
<person name="Iannaccone C."/>
<person name="Cernadas M."/>
<person name="Weinblatt M."/>
<person name="Shadick N."/>
<person name="Miaw S.C."/>
<person name="Ho I.C."/>
</authorList>
<dbReference type="PubMed" id="22427951"/>
<dbReference type="DOI" id="10.1371/journal.pone.0033067"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 6)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="Immunity" volume="39" first="111" last="122">
<title>The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.</title>
<authorList>
<person name="Wang Y."/>
<person name="Shaked I."/>
<person name="Stanford S.M."/>
<person name="Zhou W."/>
<person name="Curtsinger J.M."/>
<person name="Mikulski Z."/>
<person name="Shaheen Z.R."/>
<person name="Cheng G."/>
<person name="Sawatzke K."/>
<person name="Campbell A.M."/>
<person name="Auger J.L."/>
<person name="Bilgic H."/>
<person name="Shoyama F.M."/>
<person name="Schmeling D.O."/>
<person name="Balfour H.H. Jr."/>
<person name="Hasegawa K."/>
<person name="Chan A.C."/>
<person name="Corbett J.A."/>
<person name="Binstadt B.A."/>
<person name="Mescher M.F."/>
<person name="Ley K."/>
<person name="Bottini N."/>
<person name="Peterson E.J."/>
</authorList>
<dbReference type="PubMed" id="23871208"/>
<dbReference type="DOI" id="10.1016/j.immuni.2013.06.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TRAF3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-449</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E72384" last="E72384">
<title>Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy.</title>
<authorList>
<person name="Spalinger M.R."/>
<person name="Lang S."/>
<person name="Vavricka S.R."/>
<person name="Fried M."/>
<person name="Rogler G."/>
<person name="Scharl M."/>
</authorList>
<dbReference type="PubMed" id="23991106"/>
<dbReference type="DOI" id="10.1371/journal.pone.0072384"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="19767" last="19772">
<title>Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.</title>
<authorList>
<person name="Yu X."/>
<person name="Sun J.P."/>
<person name="He Y."/>
<person name="Guo X."/>
<person name="Liu S."/>
<person name="Zhou B."/>
<person name="Hudmon A."/>
<person name="Zhang Z.Y."/>
</authorList>
<dbReference type="PubMed" id="18056643"/>
<dbReference type="DOI" id="10.1073/pnas.0706233104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-294 IN COMPLEX WITH INHIBITOR</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-35</scope>
<scope>MUTAGENESIS OF SER-35 AND THR-36</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="4838" last="4845">
<title>Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation.</title>
<authorList>
<person name="Tsai S.J."/>
<person name="Sen U."/>
<person name="Zhao L."/>
<person name="Greenleaf W.B."/>
<person name="Dasgupta J."/>
<person name="Fiorillo E."/>
<person name="Orru V."/>
<person name="Bottini N."/>
<person name="Chen X.S."/>
</authorList>
<dbReference type="PubMed" id="19371084"/>
<dbReference type="DOI" id="10.1021/bi900166y"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-302</scope>
<scope>DISULFIDE BOND</scope>
<scope>MUTAGENESIS OF CYS-129 AND CYS-231</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Cell" volume="136" first="352" last="363">
<title>Large-scale structural analysis of the classical human protein tyrosine phosphatome.</title>
<authorList>
<person name="Barr A.J."/>
<person name="Ugochukwu E."/>
<person name="Lee W.H."/>
<person name="King O.N.F."/>
<person name="Filippakopoulos P."/>
<person name="Alfano I."/>
<person name="Savitsky P."/>
<person name="Burgess-Brown N.A."/>
<person name="Mueller S."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="19167335"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.11.038"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-302</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Hum. Mol. Genet." volume="18" first="569" last="579">
<title>A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus.</title>
<authorList>
<person name="Orru V."/>
<person name="Tsai S.J."/>
<person name="Rueda B."/>
<person name="Fiorillo E."/>
<person name="Stanford S.M."/>
<person name="Dasgupta J."/>
<person name="Hartiala J."/>
<person name="Zhao L."/>
<person name="Ortego-Centeno N."/>
<person name="D'Alfonso S."/>
<person name="Arnett F.C."/>
<person name="Wu H."/>
<person name="Gonzalez-Gay M.A."/>
<person name="Tsao B.P."/>
<person name="Pons-Estel B."/>
<person name="Alarcon-Riquelme M.E."/>
<person name="He Y."/>
<person name="Zhang Z.Y."/>
<person name="Allayee H."/>
<person name="Chen X.S."/>
<person name="Martin J."/>
<person name="Bottini N."/>
<person name="Danieli M.G."/>
<person name="Galeazzi M."/>
<person name="Sabbadini M.G."/>
<person name="Migliaresi S."/>
<person name="Sebastiani G.D."/>
</authorList>
<dbReference type="PubMed" id="18981062"/>
<dbReference type="DOI" id="10.1093/hmg/ddn363"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 2-309 OF WILD TYPE AND VARIANT GLN-263</scope>
<scope>VARIANT GLN-263</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANT GLN-263</scope>
</reference>
<reference key="19">
<citation type="submission" date="2009-12" db="PDB data bank">
<title>Lyp/PTPN22 phosphatase domain: substrate recognition and specificity for Src family kinases.</title>
<authorList>
<person name="Seidel R.D."/>
<person name="Love J."/>
<person name="Piserchio A."/>
<person name="Cowburn D."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-310 IN COMPLEX WITH SUBSTRATE</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="30526" last="30534">
<title>Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55 kDa homolog (SKAP-HOM) as a Lyp substrate.</title>
<authorList>
<person name="Yu X."/>
<person name="Chen M."/>
<person name="Zhang S."/>
<person name="Yu Z.H."/>
<person name="Sun J.P."/>
<person name="Wang L."/>
<person name="Liu S."/>
<person name="Imasaki T."/>
<person name="Takagi Y."/>
<person name="Zhang Z.Y."/>
</authorList>
<dbReference type="PubMed" id="21719704"/>
<dbReference type="DOI" id="10.1074/jbc.m111.254722"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-294 OF MUTANT SER-227 ALONE AND IN COMPLEX WITH SKAP2 PEPTIDE</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Am. J. Hum. Genet." volume="75" first="330" last="337">
<title>A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.</title>
<authorList>
<person name="Begovich A.B."/>
<person name="Carlton V.E."/>
<person name="Honigberg L.A."/>
<person name="Schrodi S.J."/>
<person name="Chokkalingam A.P."/>
<person name="Alexander H.C."/>
<person name="Ardlie K.G."/>
<person name="Huang Q."/>
<person name="Smith A.M."/>
<person name="Spoerke J.M."/>
<person name="Conn M.T."/>
<person name="Chang M."/>
<person name="Chang S.Y."/>
<person name="Saiki R.K."/>
<person name="Catanese J.J."/>
<person name="Leong D.U."/>
<person name="Garcia V.E."/>
<person name="McAllister L.B."/>
<person name="Jeffery D.A."/>
<person name="Lee A.T."/>
<person name="Batliwalla F."/>
<person name="Remmers E."/>
<person name="Criswell L.A."/>
<person name="Seldin M.F."/>
<person name="Kastner D.L."/>
<person name="Amos C.I."/>
<person name="Sninsky J.J."/>
<person name="Gregersen P.K."/>
</authorList>
<dbReference type="PubMed" id="15208781"/>
<dbReference type="DOI" id="10.1086/422827"/>
</citation>
<scope>VARIANT RA TRP-620</scope>
<scope>INTERACTION WITH CSK</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Am. J. Hum. Genet." volume="75" first="504" last="507">
<title>Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.</title>
<authorList>
<person name="Kyogoku C."/>
<person name="Langefeld C.D."/>
<person name="Ortmann W.A."/>
<person name="Lee A."/>
<person name="Selby S."/>
<person name="Carlton V.E.H."/>
<person name="Chang M."/>
<person name="Ramos P."/>
<person name="Baechler E.C."/>
<person name="Batliwalla F.M."/>
<person name="Novitzke J."/>
<person name="Williams A.H."/>
<person name="Gillett C."/>
<person name="Rodine P."/>
<person name="Graham R.R."/>
<person name="Ardlie K.G."/>
<person name="Gaffney P.M."/>
<person name="Moser K.L."/>
<person name="Petri M."/>
<person name="Begovich A.B."/>
<person name="Gregersen P.K."/>
<person name="Behrens T.W."/>
</authorList>
<dbReference type="PubMed" id="15273934"/>
<dbReference type="DOI" id="10.1086/423790"/>
</citation>
<scope>VARIANT SLE TRP-620</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="337" last="338">
<title>A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.</title>
<authorList>
<person name="Bottini N."/>
<person name="Musumeci L."/>
<person name="Alonso A."/>
<person name="Rahmouni S."/>
<person name="Nika K."/>
<person name="Rostamkhani M."/>
<person name="MacMurray J."/>
<person name="Meloni G.F."/>
<person name="Lucarelli P."/>
<person name="Pellecchia M."/>
<person name="Eisenbarth G.S."/>
<person name="Comings D."/>
<person name="Mustelin T."/>
</authorList>
<dbReference type="PubMed" id="15004560"/>
<dbReference type="DOI" id="10.1038/ng1323"/>
</citation>
<scope>VARIANT IDDM TRP-620</scope>
<scope>CHARACTERIZATION OF VARIANT IDDM TRP-620</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="5862" last="5865">
<title>The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.</title>
<authorList>
<person name="Velaga M.R."/>
<person name="Wilson V."/>
<person name="Jennings C.E."/>
<person name="Owen C.J."/>
<person name="Herington S."/>
<person name="Donaldson P.T."/>
<person name="Ball S.G."/>
<person name="James R.A."/>
<person name="Quinton R."/>
<person name="Perros P."/>
<person name="Pearce S.H."/>
</authorList>
<dbReference type="PubMed" id="15531553"/>
<dbReference type="DOI" id="10.1210/jc.2004-1108"/>
</citation>
<scope>INVOLVEMENT IN GRAVES DISEASE</scope>
<scope>INVOLVEMENT IN ADDISON DISEASE</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="76" first="561" last="571">
<title>Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.</title>
<authorList>
<person name="Criswell L.A."/>
<person name="Pfeiffer K.A."/>
<person name="Lum R.F."/>
<person name="Gonzales B."/>
<person name="Novitzke J."/>
<person name="Kern M."/>
<person name="Moser K.L."/>
<person name="Begovich A.B."/>
<person name="Carlton V.E."/>
<person name="Li W."/>
<person name="Lee A.T."/>
<person name="Ortmann W."/>
<person name="Behrens T.W."/>
<person name="Gregersen P.K."/>
</authorList>
<dbReference type="PubMed" id="15719322"/>
<dbReference type="DOI" id="10.1086/429096"/>
</citation>
<scope>INVOLVEMENT IN HASHIMOTO THYROIDITIS</scope>
<scope>VARIANT TRP-620</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Genes Immun." volume="6" first="584" last="587">
<title>A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.</title>
<authorList>
<person name="Canton I."/>
<person name="Akhtar S."/>
<person name="Gavalas N.G."/>
<person name="Gawkrodger D.J."/>
<person name="Blomhoff A."/>
<person name="Watson P.F."/>
<person name="Weetman A.P."/>
<person name="Kemp E.H."/>
</authorList>
<dbReference type="PubMed" id="16015369"/>
<dbReference type="DOI" id="10.1038/sj.gene.6364243"/>
</citation>
<scope>VARIANT VTLG TRP-620</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="J. Immunol." volume="182" first="3343" last="3347">
<title>Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.</title>
<authorList>
<person name="Arechiga A.F."/>
<person name="Habib T."/>
<person name="He Y."/>
<person name="Zhang X."/>
<person name="Zhang Z.Y."/>
<person name="Funk A."/>
<person name="Buckner J.H."/>
</authorList>
<dbReference type="PubMed" id="19265110"/>
<dbReference type="DOI" id="10.4049/jimmunol.0713370"/>
</citation>
<scope>VARIANT TRP-620</scope>
<scope>CHARACTERIZATION OF VARIANT TRP-620</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Inflamm. Bowel Dis." volume="17" first="2287" last="2294">
<title>Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis.</title>
<authorList>
<person name="Diaz-Gallo L.M."/>
<person name="Espino-Paisan L."/>
<person name="Fransen K."/>
<person name="Gomez-Garcia M."/>
<person name="van Sommeren S."/>
<person name="Cardena C."/>
<person name="Rodrigo L."/>
<person name="Mendoza J.L."/>
<person name="Taxonera C."/>
<person name="Nieto A."/>
<person name="Alcain G."/>
<person name="Cueto I."/>
<person name="Lopez-Nevot M.A."/>
<person name="Bottini N."/>
<person name="Barclay M.L."/>
<person name="Crusius J.B."/>
<person name="van Bodegraven A.A."/>
<person name="Wijmenga C."/>
<person name="Ponsioen C.Y."/>
<person name="Gearry R.B."/>
<person name="Roberts R.L."/>
<person name="Weersma R.K."/>
<person name="Urcelay E."/>
<person name="Merriman T.R."/>
<person name="Alizadeh B.Z."/>
<person name="Martin J."/>
</authorList>
<dbReference type="PubMed" id="21287672"/>
<dbReference type="DOI" id="10.1002/ibd.21630"/>
</citation>
<scope>VARIANTS GLN-263 AND TRP-620</scope>
<scope>CHARACTERIZATION OF VARIANTS GLN-263 AND TRP-620</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E43631" last="E43631">
<title>Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.</title>
<authorList>
<person name="Liu J."/>
<person name="Chen M."/>
<person name="Li R."/>
<person name="Yang F."/>
<person name="Shi X."/>
<person name="Zhu L."/>
<person name="Wang H.M."/>
<person name="Yao W."/>
<person name="Liu Q."/>
<person name="Meng F.G."/>
<person name="Sun J.P."/>
<person name="Pang Q."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="22952725"/>
<dbReference type="DOI" id="10.1371/journal.pone.0043631"/>
</citation>
<scope>VARIANTS PHE-201; GLN-263 AND TRP-266</scope>
<scope>CHARACTERIZATION OF VARIANTS PHE-201; GLN-263 AND TRP-266</scope>
</reference>
<comment type="function">
<text evidence="8 18 20 22 27 29 30">Acts as negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules (PubMed:16461343, PubMed:18056643). Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue (PubMed:21719704). Dephosphorylates ZAP70 at its activating 'Tyr-493' residue (PubMed:16461343). Dephosphorylates the immune system activator SKAP2 (PubMed:21719704). Positively regulates toll-like receptor (TLR)-induced type 1 interferon production (PubMed:23871208). Promotes host antiviral responses mediated by type 1 interferon (By similarity). Regulates NOD2-induced pro-inflammatory cytokine secretion and autophagy (PubMed:23991106).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="10 27">
<text>H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:10684"/>
<dbReference type="Rhea" id="RHEA-COMP:10136"/>
<dbReference type="Rhea" id="RHEA-COMP:10137"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:46858"/>
<dbReference type="ChEBI" id="CHEBI:82620"/>
<dbReference type="EC" id="3.1.3.48"/>
</reaction>
</comment>
<comment type="activity regulation">
<text>Down-regulated by phosphorylation.</text>
</comment>
<comment type="subunit">
<text evidence="8 11 13 20 27 29 31">Interacts with CSK (PubMed:15208781). Interacts with LPXN (By similarity). Interacts with CBL (PubMed:10068674). Interacts with TRAF3 (via MATH domain); the interaction promotes TRAF3 polyubiquitination (PubMed:23871208).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-1165705">
<id>P20963</id>
<label>CD247</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-1050964">
<id>O43586</id>
<label>PSTPIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-2483161">
<id>O75563</id>
<label>SKAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-357631">
<id>Q13114</id>
<label>TRAF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-642769">
<id>Q3UND0</id>
<label>Skap2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
</interactant>
<interactant intactId="EBI-520135">
<id>Q60803</id>
<label>Traf3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y2R2-1</id>
<name>1</name>
<name>LyP1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y2R2-2</id>
<name>2</name>
<name>LyP2</name>
<sequence type="described" ref="VSP_005134"/>
</isoform>
<isoform>
<id>Q9Y2R2-3</id>
<name>3</name>
<sequence type="described" ref="VSP_039728"/>
</isoform>
<isoform>
<id>Q9Y2R2-4</id>
<name>4</name>
<name>LYP3</name>
<sequence type="described" ref="VSP_039729"/>
</isoform>
<isoform>
<id>Q9Y2R2-5</id>
<name>5</name>
<sequence type="described" ref="VSP_039725 VSP_039726 VSP_039727"/>
</isoform>
<isoform>
<id>Q9Y2R2-6</id>
<name>6</name>
<name>PTPN22.6</name>
<sequence type="described" ref="VSP_044428 VSP_044429"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13">Expressed in bone marrow, B and T-cells, PBMCs, natural killer cells, monocytes, dendritic cells and neutrophils (PubMed:15208781). Both isoform 1 and 4 are predominantly expressed in lymphoid tissues and cells. Isoform 1 is expressed in thymocytes and both mature B and T-cells.</text>
</comment>
<comment type="induction">
<text evidence="30">By muramyl-dipeptide and lipopolysaccharide.</text>
</comment>
<comment type="PTM">
<text evidence="20">Phosphorylation on Ser-35 by PKC/PRKCD abrogates its ability to dephosphorylate and inactivate the SRC family kinases.</text>
</comment>
<comment type="disease" evidence="14">
<disease id="DI-02648">
<name>Systemic lupus erythematosus</name>
<acronym>SLE</acronym>
<description>A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.</description>
<dbReference type="MIM" id="152700"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="12">
<disease id="DI-01826">
<name>Diabetes mellitus, insulin-dependent</name>
<acronym>IDDM</acronym>
<description>A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.</description>
<dbReference type="MIM" id="222100"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-02692">
<name>Rheumatoid arthritis</name>
<acronym>RA</acronym>
<description>An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures.</description>
<dbReference type="MIM" id="180300"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="17">
<disease id="DI-02735">
<name>Vitiligo</name>
<acronym>VTLG</acronym>
<description>A pigmentary disorder of the skin and mucous membranes. It is characterized by circumscribed depigmented macules and patches, commonly on extensor aspects of extremities, on the face or neck and in skin folds. Vitiligo is a progressive disorder in which some or all of the melanocytes in the affected skin are selectively destroyed. It is a multifactorial disorder with a complex etiology probably including autoimmune mechanisms, and is associated with an elevated risk of other autoimmune diseases.</description>
<dbReference type="MIM" id="193200"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="38">Due to intron retention.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 6</molecule>
<text evidence="38">Lacks most of the phosphatase domain and functions as a dominant negative isoform of the full length PTPN22.</text>
</comment>
<comment type="similarity">
<text evidence="38">Belongs to the protein-tyrosine phosphatase family. Non-receptor class 4 subfamily.</text>
</comment>
<dbReference type="EC" id="3.1.3.48" evidence="27"/>
<dbReference type="EMBL" id="AF001846">
<property type="protein sequence ID" value="AAD00904.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF001847">
<property type="protein sequence ID" value="AAD00905.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU479452">
<property type="protein sequence ID" value="ADD59979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF077031">
<property type="protein sequence ID" value="AAD27764.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK310570">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF064714">
<property type="protein sequence ID" value="ABK41897.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137856">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471122">
<property type="protein sequence ID" value="EAW56575.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471122">
<property type="protein sequence ID" value="EAW56576.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017785">
<property type="protein sequence ID" value="AAH17785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071670">
<property type="protein sequence ID" value="AAH71670.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS863.1">
<molecule id="Q9Y2R2-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS864.2">
<molecule id="Q9Y2R2-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180360.1">
<molecule id="Q9Y2R2-4"/>
<property type="nucleotide sequence ID" value="NM_001193431.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001295226.1">
<property type="nucleotide sequence ID" value="NM_001308297.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036543.4">
<molecule id="Q9Y2R2-3"/>
<property type="nucleotide sequence ID" value="NM_012411.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057051.3">
<molecule id="Q9Y2R2-1"/>
<property type="nucleotide sequence ID" value="NM_015967.6"/>
</dbReference>
<dbReference type="PDB" id="2P6X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-302"/>
</dbReference>
<dbReference type="PDB" id="2QCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="2QCT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="3BRH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=1-310"/>
</dbReference>
<dbReference type="PDB" id="3H2X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-302"/>
</dbReference>
<dbReference type="PDB" id="3OLR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=1-294"/>
</dbReference>
<dbReference type="PDB" id="3OMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=1-294"/>
</dbReference>
<dbReference type="PDB" id="4J51">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=1-303"/>
</dbReference>
<dbReference type="PDBsum" id="2P6X"/>
<dbReference type="PDBsum" id="2QCJ"/>
<dbReference type="PDBsum" id="2QCT"/>
<dbReference type="PDBsum" id="3BRH"/>
<dbReference type="PDBsum" id="3H2X"/>
<dbReference type="PDBsum" id="3OLR"/>
<dbReference type="PDBsum" id="3OMH"/>
<dbReference type="PDBsum" id="4J51"/>
<dbReference type="SMR" id="Q9Y2R2"/>
<dbReference type="BioGRID" id="117604">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="DIP" id="DIP-29953N"/>
<dbReference type="IntAct" id="Q9Y2R2">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="Q9Y2R2"/>
<dbReference type="STRING" id="9606.ENSP00000352833"/>
<dbReference type="BindingDB" id="Q9Y2R2"/>
<dbReference type="ChEMBL" id="CHEMBL2889"/>
<dbReference type="GuidetoPHARMACOLOGY" id="3084"/>
<dbReference type="DEPOD" id="PTPN22"/>
<dbReference type="iPTMnet" id="Q9Y2R2"/>
<dbReference type="PhosphoSitePlus" id="Q9Y2R2"/>
<dbReference type="BioMuta" id="PTPN22"/>
<dbReference type="DMDM" id="20139861"/>
<dbReference type="jPOST" id="Q9Y2R2"/>
<dbReference type="MassIVE" id="Q9Y2R2"/>
<dbReference type="PaxDb" id="Q9Y2R2"/>
<dbReference type="PeptideAtlas" id="Q9Y2R2"/>
<dbReference type="PRIDE" id="Q9Y2R2"/>
<dbReference type="ProteomicsDB" id="21761"/>
<dbReference type="ProteomicsDB" id="22726"/>
<dbReference type="ProteomicsDB" id="85874">
<molecule id="Q9Y2R2-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85875">
<molecule id="Q9Y2R2-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85876">
<molecule id="Q9Y2R2-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85877">
<molecule id="Q9Y2R2-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="85878">
<molecule id="Q9Y2R2-5"/>
</dbReference>
<dbReference type="Antibodypedia" id="33846">
<property type="antibodies" value="294 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="26191"/>
<dbReference type="Ensembl" id="ENST00000460620">
<molecule id="Q9Y2R2-5"/>
<property type="protein sequence ID" value="ENSP00000433141"/>
<property type="gene ID" value="ENSG00000134242"/>
</dbReference>
<dbReference type="GeneID" id="26191"/>
<dbReference type="KEGG" id="hsa:26191"/>
<dbReference type="UCSC" id="uc001edt.4">
<molecule id="Q9Y2R2-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="26191"/>
<dbReference type="DisGeNET" id="26191"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000134242.15"/>
<dbReference type="GeneCards" id="PTPN22"/>
<dbReference type="HGNC" id="HGNC:9652">
<property type="gene designation" value="PTPN22"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000134242">
<property type="expression patterns" value="Tissue enhanced (bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="PTPN22"/>
<dbReference type="MIM" id="152700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="180300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="193200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="222100">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600716">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y2R2"/>
<dbReference type="OpenTargets" id="ENSG00000134242"/>
<dbReference type="Orphanet" id="397">
<property type="disease" value="Giant cell arteritis"/>
</dbReference>
<dbReference type="Orphanet" id="900">
<property type="disease" value="Granulomatosis with polyangiitis"/>
</dbReference>
<dbReference type="Orphanet" id="85410">
<property type="disease" value="Oligoarticular juvenile idiopathic arthritis"/>
</dbReference>
<dbReference type="Orphanet" id="85408">
<property type="disease" value="Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis"/>
</dbReference>
<dbReference type="Orphanet" id="536">
<property type="disease" value="Systemic lupus erythematosus"/>
</dbReference>
<dbReference type="Orphanet" id="3437">
<property type="disease" value="Vogt-Koyanagi-Harada disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33995"/>
<dbReference type="eggNOG" id="KOG0789">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160958"/>
<dbReference type="InParanoid" id="Q9Y2R2"/>
<dbReference type="KO" id="K18024"/>
<dbReference type="PhylomeDB" id="Q9Y2R2"/>
<dbReference type="TreeFam" id="TF351977"/>
<dbReference type="BRENDA" id="3.1.3.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q9Y2R2"/>
<dbReference type="Reactome" id="R-HSA-202427">
<property type="pathway name" value="Phosphorylation of CD3 and TCR zeta chains"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202430">
<property type="pathway name" value="Translocation of ZAP-70 to Immunological synapse"/>
</dbReference>
<dbReference type="SignaLink" id="Q9Y2R2"/>
<dbReference type="SIGNOR" id="Q9Y2R2"/>
<dbReference type="BioGRID-ORCS" id="26191">
<property type="hits" value="7 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PTPN22">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y2R2"/>
<dbReference type="GeneWiki" id="PTPN22"/>
<dbReference type="GenomeRNAi" id="26191"/>
<dbReference type="Pharos" id="Q9Y2R2">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9Y2R2"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q9Y2R2">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000134242">
<property type="expression patterns" value="Expressed in bone marrow and 154 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9Y2R2">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y2R2">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004726">
<property type="term" value="F:non-membrane spanning protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016791">
<property type="term" value="F:phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004725">
<property type="term" value="F:protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071225">
<property type="term" value="P:cellular response to muramyl dipeptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032715">
<property type="term" value="P:negative regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032717">
<property type="term" value="P:negative regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043508">
<property type="term" value="P:negative regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070433">
<property type="term" value="P:negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903753">
<property type="term" value="P:negative regulation of p38MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050868">
<property type="term" value="P:negative regulation of T cell activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050860">
<property type="term" value="P:negative regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032720">
<property type="term" value="P:negative regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035335">
<property type="term" value="P:peptidyl-tyrosine dephosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035644">
<property type="term" value="P:phosphoanandamide dephosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000566">
<property type="term" value="P:positive regulation of CD8-positive, alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0002230">
<property type="term" value="P:positive regulation of defense response to virus by host"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071663">
<property type="term" value="P:positive regulation of granzyme B production"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032729">
<property type="term" value="P:positive regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902523">
<property type="term" value="P:positive regulation of protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034141">
<property type="term" value="P:positive regulation of toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034145">
<property type="term" value="P:positive regulation of toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034157">
<property type="term" value="P:positive regulation of toll-like receptor 7 signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034165">
<property type="term" value="P:positive regulation of toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006470">
<property type="term" value="P:protein dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050855">
<property type="term" value="P:regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045088">
<property type="term" value="P:regulation of innate immune response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032817">
<property type="term" value="P:regulation of natural killer cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901222">
<property type="term" value="P:regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030217">
<property type="term" value="P:T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.190.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029021">
<property type="entry name" value="Prot-tyrosine_phosphatase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR000242">
<property type="entry name" value="PTPase_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR016276">
<property type="entry name" value="PTPN22"/>
</dbReference>
<dbReference type="InterPro" id="IPR016130">
<property type="entry name" value="Tyr_Pase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003595">
<property type="entry name" value="Tyr_Pase_cat"/>
</dbReference>
<dbReference type="InterPro" id="IPR000387">
<property type="entry name" value="TYR_PHOSPHATASE_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00102">
<property type="entry name" value="Y_phosphatase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000930">
<property type="entry name" value="PTPN8_PTPN22"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00700">
<property type="entry name" value="PRTYPHPHTASE"/>
</dbReference>
<dbReference type="SMART" id="SM00194">
<property type="entry name" value="PTPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00404">
<property type="entry name" value="PTPc_motif"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52799">
<property type="entry name" value="SSF52799"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00383">
<property type="entry name" value="TYR_PHOSPHATASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50056">
<property type="entry name" value="TYR_PHOSPHATASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50055">
<property type="entry name" value="TYR_PHOSPHATASE_PTP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0772">Systemic lupus erythematosus</keyword>
<feature type="chain" description="Tyrosine-protein phosphatase non-receptor type 22" id="PRO_0000094775">
<location>
<begin position="1"/>
<end position="807"/>
</location>
</feature>
<feature type="domain" description="Tyrosine-protein phosphatase" evidence="9">
<location>
<begin position="24"/>
<end position="289"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="227"/>
<end position="233"/>
</location>
</feature>
<feature type="active site" description="Phosphocysteine intermediate" evidence="9 10">
<location>
<position position="227"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="7">
<location>
<position position="195"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="31">
<location>
<position position="274"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCD" evidence="20">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="449"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="635"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="684"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="692"/>
</location>
</feature>
<feature type="disulfide bond" evidence="24">
<location>
<begin position="129"/>
<end position="227"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_044428" evidence="35">
<location>
<begin position="124"/>
<end position="250"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_039725" evidence="36">
<location>
<begin position="137"/>
<end position="160"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_039726" evidence="36">
<original>ETRTIYQFHYKNWPDHDVPSSID</original>
<variation>VSVILAHQTSLQNLFSQITPAHF</variation>
<location>
<begin position="181"/>
<end position="203"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_039727" evidence="36">
<location>
<begin position="204"/>
<end position="807"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_039728" evidence="36">
<location>
<begin position="251"/>
<end position="305"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_039729" evidence="37">
<location>
<begin position="647"/>
<end position="674"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005134" evidence="34">
<original>ELHQDRSSPPPPLPERTLESFFLADEDCMQAQSIETYSTSYPDTMENSTSSKQTLKTPGKSFTRSKSLKILRNMKKSICNSCPPNKPAESVQSNNSSSFLNFGFANRFSKPKGPRNPPPTWNI</original>
<variation>GKNFSWL</variation>
<location>
<begin position="685"/>
<end position="807"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_044429" evidence="35">
<original>FANRFSKPKGPRNPPPTWNI</original>
<variation>MCVILLKS</variation>
<location>
<begin position="788"/>
<end position="807"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; moderately reduces phosphatase activity; dbSNP:rs7416347." id="VAR_072629" evidence="28">
<original>S</original>
<variation>F</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; reduces risk of SLE and RA but not IDDM; associated with reduced risk of ulcerative colitis but not of Crohn disease; severely reduces phosphatase activity; dbSNP:rs33996649." id="VAR_072630" evidence="21 26 28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; severely reduces phosphatase activity; dbSNP:rs72650670." id="VAR_072631" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDM, RA, SLE and VTLG; also found in patients with Graves disease, Hashimoto thyroiditis and Addison disease; associated with reduced risk of Crohn disease but not of ulcerative colitis; affects CSK kinase binding; alters B cell receptor signaling and memory B cell proliferation; dbSNP:rs2476601." id="VAR_022605" evidence="12 13 14 15 16 17 19 23 25 26 32 33">
<original>R</original>
<variation>W</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by PKC/PRKCD." evidence="20">
<original>S</original>
<variation>E</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on phosphorylation by PKC/PRKCD." evidence="20">
<original>T</original>
<variation>E</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases activity 2 fold." evidence="24">
<original>C</original>
<variation>S</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases activity 7 fold." evidence="24">
<original>C</original>
<variation>S</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD00904/AAD00905." ref="1" evidence="38">
<original>KP</original>
<variation>NA</variation>
<location>
<begin position="51"/>
<end position="52"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD27764." ref="2" evidence="38">
<original>V</original>
<variation>G</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD27764." ref="2" evidence="38">
<original>G</original>
<variation>V</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAD00905." ref="1" evidence="38">
<original>I</original>
<variation>IV</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AK310570." ref="4" evidence="38">
<original>A</original>
<variation>V</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD27764." ref="2" evidence="38">
<original>L</original>
<variation>P</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD27764." ref="2" evidence="38">
<original>P</original>
<variation>S</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3"/>
<end position="16"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="21"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="47"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="59"/>
<end position="62"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="80"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="86"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="110"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="156"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="167"/>
<end position="178"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="181"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="199"/>
<end position="202"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="203"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="218"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="226"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="228"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="233"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="258"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="276"/>
<end position="301"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P6X"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2QCJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BRH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OMH"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4J51"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P29352"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00160"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10044"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10068674"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15004560"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15208781"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15273934"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15531553"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15719322"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16015369"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16461343"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16710414"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056643"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18981062"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19167335"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19265110"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19371084"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21044313"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21287672"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21719704"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22952725"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23871208"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23991106"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="19"/>
</evidence>
<evidence key="32" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10068674"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21044313"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<sequence length="807" mass="91705" checksum="1ABE8AE89C9D9FBF" modified="2002-03-27" version="2">MDQREILQKFLDEAQSKKITKEEFANEFLKLKRQSTKYKADKTYPTTVAEKPKNIKKNRYKDILPYDYSRVELSLITSDEDSSYINANFIKGVYGPKAYIATQGPLSTTLLDFWRMIWEYSVLIIVMACMEYEMGKKKCERYWAEPGEMQLEFGPFSVSCEAEKRKSDYIIRTLKVKFNSETRTIYQFHYKNWPDHDVPSSIDPILELIWDVRCYQEDDSVPICIHCSAGCGRTGVICAIDYTWMLLKDGIIPENFSVFSLIREMRTQRPSLVQTQEQYELVYNAVLELFKRQMDVIRDKHSGTESQAKHCIPEKNHTLQADSYSPNLPKSTTKAAKMMNQQRTKMEIKESSSFDFRTSEISAKEELVLHPAKSSTSFDFLELNYSFDKNADTTMKWQTKAFPIVGEPLQKHQSLDLGSLLFEGCSNSKPVNAAGRYFNSKVPITRTKSTPFELIQQRETKEVDSKENFSYLESQPHDSCFVEMQAQKVMHVSSAELNYSLPYDSKHQIRNASNVKHHDSSALGVYSYIPLVENPYFSSWPPSGTSSKMSLDLPEKQDGTVFPSSLLPTSSTSLFSYYNSHDSLSLNSPTNISSLLNQESAVLATAPRIDDEIPPPLPVRTPESFIVVEEAGEFSPNVPKSLSSAVKVKIGTSLEWGGTSEPKKFDDSVILRPSKSVKLRSPKSELHQDRSSPPPPLPERTLESFFLADEDCMQAQSIETYSTSYPDTMENSTSSKQTLKTPGKSFTRSKSLKILRNMKKSICNSCPPNKPAESVQSNNSSSFLNFGFANRFSKPKGPRNPPPTWNI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

